NSN 6505-01-099-4064 of Chlordiazepoxide Hy - Parts Details
Alternative NSN: 6505010994064 |
Item Name: Chlordiazepoxide Hy |
FSG: 65 Medical Dental and Veterinary Equipment and Supplies |
Federal Supply Class (FSC): 6505 Drugs and Biologicals |
NIIN: 010994064 |
NCB Code: USA (01) |
Manufacturers: Mylan Institutional Llc , Par Pharmaceutical Inc , Danbury Pharmacal Inc , Barr Laboratories Inc , Valeant Pharmaceuticals |
ASAP Aviation Procurement, owned and operated by ASAP Semiconductor, is the latest parts procurement platform for the aerospace and aviation industry. Check out high demanding part numbers NDC51079-0375-21, NDC51079-0375-20, NDC49884-0959-01, NDC00591-0786-01, NDC00555-0033-02 under NSN 6505-01-099-4064 of Chlordiazepoxide Hy manufactured by Mylan Institutional Llc, Par Pharmaceutical Inc, Danbury Pharmacal Inc, Barr Laboratories Inc, Valeant Pharmaceuticals.
Federal Supply Class of NSN 6505-01-099-4064 is FSC 6505 contains part details of Drugs and Biologicals. Quote for your desired part numbers.
Part Number's List for NSN 6505-01-099-4064, 6505010994064
-
Part No Manufacturer Item Name QTY RFQ NDC51079-0375-21 Mylan Institutional Llc chlordiazepoxide hy Avl RFQ NDC51079-0375-20 Mylan Institutional Llc chlordiazepoxide hy Avl RFQ NDC49884-0959-01 Par Pharmaceutical Inc chlordiazepoxide hy Avl RFQ NDC00591-0786-01 Danbury Pharmacal Inc chlordiazepoxide hy Avl RFQ NDC00555-0033-02 Barr Laboratories Inc chlordiazepoxide hy Avl RFQ NDC00187-3751-10 Valeant Pharmaceuticals chlordiazepoxide hy Avl RFQ
Characteristics Data of NSN 6505010994064MRC Criteria Characteristic AJCN PROTECTIVE STORAGE FEATURE SECURITY STORAGE AKJA ACTIVE MEDICAMENT MEDICINAL STRENGTH 10.000 MILLIGRAMS CHLORDIAZEPOXIDE HYDROCHLORIDE ACTIVE INGREDIENT AKJC CAPSULE TYPE HARD CBBL FEATURES PROVIDED INDIVIDUALLY SEALED CQCT PRIMARY CONTAINER TYPE STRIP, ROLL CQGK SECONDARY CONTAINER TYPE BOX CQLS CAPSULE CONTENT FORM POWDER CRXL PRIMARY CONTAINER QUANTITY PER SECONDARY CONTAINER 1 STRIP, ROLL CSCW TOTAL PRIMARY CONTAINER QUANTITY 4 CSCX TOTAL SECONDARY CONTAINER QUANTITY 4 CXCY III PART NAME ASSIGNED BY CONTROLLING AGENCY CHLORDIAZEPOXIDE HYDROCHLORIDE CAPSULES USP 10MG I.S. 100S CYLZ CAPSULE PRIMARY CONTAINER CONTENT QUANTITY 25.000 FEAT SPECIAL FEATURES REVERSE-NUMBERED ROLLED STRIPS MDES MEDICAL DESIGNATION AND GRADE UNITED STATES PHARMACOPEIA SUPP SUPPLEMENTARY FEATURES CONSISTS OF 4 BOXES EA CONTAINING 25 CAPSULES
MRC | Criteria | Characteristic |
---|---|---|
AJCN | PROTECTIVE STORAGE FEATURE | SECURITY STORAGE |
AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 10.000 MILLIGRAMS CHLORDIAZEPOXIDE HYDROCHLORIDE ACTIVE INGREDIENT |
AKJC | CAPSULE TYPE | HARD |
CBBL | FEATURES PROVIDED | INDIVIDUALLY SEALED |
CQCT | PRIMARY CONTAINER TYPE | STRIP, ROLL |
CQGK | SECONDARY CONTAINER TYPE | BOX |
CQLS | CAPSULE CONTENT FORM | POWDER |
CRXL | PRIMARY CONTAINER QUANTITY PER SECONDARY CONTAINER | 1 STRIP, ROLL |
CSCW | TOTAL PRIMARY CONTAINER QUANTITY | 4 |
CSCX | TOTAL SECONDARY CONTAINER QUANTITY | 4 |
CXCY | III PART NAME ASSIGNED BY CONTROLLING AGENCY | CHLORDIAZEPOXIDE HYDROCHLORIDE CAPSULES USP 10MG I.S. 100S |
CYLZ | CAPSULE PRIMARY CONTAINER CONTENT QUANTITY | 25.000 |
FEAT | SPECIAL FEATURES | REVERSE-NUMBERED ROLLED STRIPS |
MDES | MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
SUPP | SUPPLEMENTARY FEATURES | CONSISTS OF 4 BOXES EA CONTAINING 25 CAPSULES |